CannIntelligence, Author at CannIntelligence | Page 9 of 25

CBD-Intel regulatory news in brief, 17th-23rd April

Written by CannIntelligence || 23rd April 2021 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from Germany, Latvia Malta, Netherlands, Poland, Spain, UK, Canada, US, China, Lesotho and...

How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?

Written by CannIntelligence || 22nd April 2021 || Blogs |

It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in...

CBD and Covid-19 – lab experiments show promise, but don’t hold your breath

Written by CannIntelligence || 21st April 2021 || News analysis |

Early research into the possibility of CBD having a role to play in the fight against coronavirus infections has shown some initial promise. Any practical application remains a long way off, however ...

A new head honcho for CBD policy – but who will US FDA pick for this vital role?

Written by CannIntelligence || 19th April 2021 || News analysis |

A new deputy commissioner at the US Food and Drug Administration (FDA) will likely be the single person with the most influence on the path to market for CBD in the US ...

The next big thing – or are investors in psychedelics playing the long game?

Written by CannIntelligence || 19th April 2021 || News analysis |

While legal cannabis is still a relatively new industry, investors are already looking for the next sector to boom – and many think that will be psychedelics ...

Credit union runs into trouble with US agency over too-lax cannabis activities

Written by CannIntelligence || 16th April 2021 || News analysis |

Access to banking services has been a problem for the legal cannabis sector in the US from the beginning – and the experience of one cooperative in Michigan shows that the relationship can be problematic for financial institutions...

CBD-Intel regulatory news in brief, 10th-16th April

Written by CannIntelligence || 16th April 2021 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from France, Italy, Lithuania, Malta, Norway, Poland, Spain, Sweden, Ukraine and the US ...

New Senate request could hold Mexican legalisation back until at least September

Written by CannIntelligence || 15th April 2021 || News analysis |

Mexico’s Senate is poised to request extra time to approve legislation that would legalise cannabis in the country, prolonging debate over the highly anticipated bill until September ...

Details of China’s proposed ban on CBD in cosmetics still unclear

Written by CannIntelligence || 14th April 2021 || News analysis |

Suggestions that a Chinese ban on the use of CBD in cosmetics that would essentially shut down the domestic CBD market, blocking imports and cross-border online sales, appear to be premature ...

Is delta-8 THC really the next big thing?

Written by CannIntelligence || 14th April 2021 || Blogs |

From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies...

‘A nice buzz in the air’ – CBD shops reopen as UK lockdown lifts

Written by CannIntelligence || 14th April 2021 || News analysis |

As the national lockdown in the UK lifted on Monday, shoppers were excited to purchase CBD in person ...

‘Cautious’ Idaho is ready at last to become the 50th state to legalise industrial hemp

Written by CannIntelligence || 13th April 2021 || News analysis |

It’s been a long process getting there, but the last US state to legalise industrial hemp finally has a bill headed to the governor’s desk and farmers poised to plant the crop ...

How cannabis derivatives could help to preserve the miracle of modern medicine

Written by CannIntelligence || 13th April 2021 || News analysis |

Could cannabinoids, including CBD, provide a partial solution to the growing danger of diseases becoming resistant to existing antibiotics? ...

Could cannabinoids help in the fight against drug-resistant bacteria?

Written by CannIntelligence || 12th April 2021 || News analysis |

Scientific findings on the antimicrobial properties of cannabis – and in particular cannabinoids – have raised the question of whether they might play a role in combatting antibiotic-resistant bacteria such as MRSA ...

CBD-Intel regulatory news in brief, 2nd-9th April

Written by CannIntelligence || 9th April 2021 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from Czech Republic, Belgium, the UK, Mexico and the US ...

A mixed bag: reactions to the USDA’s final hemp rule requirements

Written by CannIntelligence || 9th April 2021 || News analysis |

States continue to update their hemp production plans to match US Department of Agriculture (USDA) final rule requirements, with Michigan being one of the latest ...

Should CBD companies operating in the US be worried about the latest round of FDA enforcement?

Written by CannIntelligence || 8th April 2021 || Blogs |

Four new letters sent by the US Food and Drug Administration (FDA) in the month of April mark a bit of a change in approach. Two of them were fairly standard warnings about health claim marketing potentially in...

Italy issues its first licences to grow hemp and extract CBD for medical use

Written by CannIntelligence || 8th April 2021 || News analysis |

Italy’s Ministry of Health and the Italian Medicine Agency (AIFA) have begun authorising Italian companies to manufacture hemp-derived CBD extracts for pharmaceutical purposes ...

Regulatory report: France, April 2021

Written by CannIntelligence || 8th April 2021 || Regulatory reports |

The future regulation, and interpretation of existing rules, of cannabis in all its forms is a recurring subject in France. This report provides an overview of the current regulatory framework ...

Delta-8 THC – hot new kid on the block, or hemp’s disturbing problem child?

Written by CannIntelligence || 7th April 2021 || News analysis |

The newest cannabinoid craze is stirring up controversy in the emerging legal hemp industry. Delta-8 THC, produced from hemp-extracted CBD, promises a legal high – but, many wonder, at what cost? ...

Germany’s highest court leaves legality of hemp flowers open to interpretation

Written by CannIntelligence || 6th April 2021 || News analysis |

Germany’s highest civil and criminal court has ruled that low-THC industrial hemp flowers may be considered a narcotic – but that they can be legally sold to German consumers if there is no risk of intoxication ...

CBD firms find more pros than cons in legal recreational cannabis markets

Written by CannIntelligence || 6th April 2021 || News analysis |

CBD companies see more synergies than threats from the provision of legal cannabis products in states such as Colorado, which has one of the oldest recreational cannabis markets in the US ...

CBD-Intel regulatory news in brief, 27th March-1st April

Written by CannIntelligence || 1st April 2021 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from the Cyprus. Czech Republic, the EU, Finland, France, Germany, Iceland, Malta, Switzerland, the US, and Argentina ...

Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?

Written by CannIntelligence || 1st April 2021 || Blogs |

The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the...

Rethink needed after belated discovery that bats student confused CBD with THC

Written by CannIntelligence || 1st April 2021 || News analysis |

A lab technician’s slip-up five decades ago could cause a complete rethink of cannabis and CBD regulation in many jurisdictions, legal scholars warned today ...

‘Impending disaster’ – UK industry associations at odds over THC limits

Written by CannIntelligence || 31st March 2021 || News analysis |

The British Hemp Alliance (BHA) has contested the suggestion put forward by the Association for the Cannabinoid Industry (ACI) for allowable THC levels in CBD products, claiming it would only benefit “the big boys” ...

Could Oregon state bill show a way out of US cannabis and CBD banking troubles?

Written by CannIntelligence || 30th March 2021 || News analysis |

An Oregon senator believes he has found a solution to the cannabis banking crisis in the state, and perhaps set a useful standard for others across the US ...

The impact of CBD regulation on global markets; challenges and opportunities

Written by CannIntelligence || 26th March 2021 || Presentations , Resources |

What regulations apply to CBD around the world, how are they set to change, and what impact will the changes have on the cannabidiol sector? A presentation by CBD-Intel head of legal analysis, Pablo Cano Trilla ...

CBD-Intel regulatory news in brief, 20th-26th March

Written by CannIntelligence || 26th March 2021 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from the EU, France, Germany, the UK, the US, China and Thailand ...

FTC-targeted company remains defiant, sees administrative fine as a victory

Written by CannIntelligence || 26th March 2021 || News analysis |

The CEO of one company targeted by the US Federal Trade Commission (FTC) in the first ever group of fines handed down by the government agency to CBD companies considers the event to be a David and Goliath...

Mixed feelings as UK industry sees pros and cons in FSA switch on novel foods

Written by CannIntelligence || 25th March 2021 || News analysis |

Industry reaction to the change in UK Food Standards Agency (FSA) novel food submission requirements is mixed, some welcoming it while others say it reveals failings of management and understanding ...

Was the UK FSA decision to make changes to the novel food application timeline really that unexpected?

Written by CannIntelligence || 25th March 2021 || Blogs |

The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that...

Greece top brands pricing dashboard Q4 2020

Written by CannIntelligence || 24th March 2021 || Market data |

Welcome to the CBD-Intel top brands pricing dashboard, for insights into Greece’s most pertinent CBD brands. Find all product offerings for each brand, categorised by type of product, size, format, CBD content and their respective prices. The interactive dashboard...

Podcast: what lies beyond North America’s legal cannabis market?

Written by CannIntelligence || 22nd March 2021 || Podcasts , Resources |

Podcasts editor Jon Bruford is joined by Anthony Traurig, CBD-Intel legal analyst and US specialist, to discuss the legal and regulatory concerns that hang over cannabis in the US and Canada and the economic impact of Covid-19 ...

CBD-Intel regulatory news in brief, 13th-19th March

Written by CannIntelligence || 19th March 2021 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from Belgium, France, Italy, Slovakia, the UK, Canada, the US and South Africa ...

PG/phytol research should come with a health warning – lab rats are not humans

Written by CannIntelligence || 19th March 2021 || News analysis |

Any conclusion drawn from studies on rodents must be treated with caution if we want to know about effects on humans ...

What do Britons feel about CBD?

Written by CannIntelligence || 19th March 2021 || News analysis |

Taken from our recent consumer survey in the UK, this chart offers an idea of British attitudes towards...

With ingredient prices tumbling, why are CBD consumers still paying so much?

Written by CannIntelligence || 18th March 2021 || Blogs , News analysis |

A drop in the cost of bulk CBD has not yet been wholly reflected in falling CBD product prices – but are we about to witness a perfect storm for a race to the bottom? ...

Consumer survey report: CBD continues to be popular in the UK

Written by CannIntelligence || 18th March 2021 || Market reports |

This report is based on a consumer survey undertaken during December 2020 and January 2021 in order to gain insight into user types, behaviour, and preferences, along with attitudes around CBD products in the UK ...

Not now, but soon – new industry bodies prepare for Brazil opening up to hemp

Written by CannIntelligence || 18th March 2021 || News analysis |

Brazil still faces a serious attitude problem when it comes to advancing regulations for hemp and CBD, according to the leaders of two recently launched industry associations in the country ...

US market to top $3bn in two years, but Swiss remain the biggest CBD users

Written by CannIntelligence || 15th March 2021 || News analysis |

Swiss consumers are head-for-head the biggest purchasers of CBD products, according to CBD-Intel’s 2021 market size analysis. Meanwhile, we predict big growth in a number of other markets, and a shift in the most popular CBD category ...

CBD-Intel regulatory news in brief, 6th-12th March

Written by CannIntelligence || 12th March 2021 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from Czech Republic, France, Greece, Switzerland, Canada, the UK, Mexico, the US, Costa Rica, China, Morocco and Taiwan ...

Pregnant mice study touches on FDA questions, but more research is needed

Written by CannIntelligence || 12th March 2021 || News analysis |

The US Food and Drug Administration (FDA) has called for an exploration of the effects of CBD on certain vulnerable populations such as children and pregnant women as part of its consumer update ...

Will the FSA-validated novel food submission list reveal commercially sensitive information?

Written by CannIntelligence || 11th March 2021 || Blogs |

There’s been some worry that the eventual list of brands with a novel food application validated by the UK Food Standards Agency (FSA) will reveal commercially sensitive information such as which brands are currently contracted to which ingredient...

Anxiety in Northern Ireland, UK’s EU gateway, as novel food deadline looms

Written by CannIntelligence || 11th March 2021 || News analysis |

As the UK’s deadline for novel food applications looms, many firms are upbeat about the prospects for CBD businesses in Northern Ireland, but almost all those CBD-Intel spoke to expressed frustration at a lack of clarity ...

Armenia looks to hemp legalisation as part of a route out of national crisis

Written by CannIntelligence || 10th March 2021 || News analysis |

Crisis-hit Armenia intends to legalise and regulate the production of hemp as a part of a package of economic measures to alleviate issues arising from the military conflict with Azerbaijan over the Nagorno-Karabakh region ...

Podcast: the changing regulatory environment for cannabis in the US

Written by CannIntelligence || 9th March 2021 || Podcasts , Resources |

CBD-Intel podcasts editor Jon Bruford is joined by the founder and principal of Kight Law Office, Rod Kight, a specialist in cannabis business law in the US ...

Pakistan moves towards a legal hemp industry under the eye of government

Written by CannIntelligence || 8th March 2021 || News analysis |

Pakistan is set to embark on a path to the legal production of hemp and hemp-derived products following the approval last September of hemp farming and processing under government control ...

CBD-Intel regulatory news in brief, 27th February-5th March

Written by CannIntelligence || 5th March 2021 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from Germany, France, Luxembourg, Malta, Poland, Spain, Mexico, the US, Brazil and...

Industry milestone as firms start to publicly list on UK stock exchange

Written by CannIntelligence || 5th March 2021 || News analysis |

Investing in the medical cannabis and CBD space in the UK is only likely to continue as companies are now legally allowed to list on Europe’s biggest stock exchange, while demand by retail investors continues to spur...

LATEST ALERTS

Written by CannIntelligence || 23rd April 2021 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 22nd April 2021 || Blogs |

Written by CannIntelligence || 21st April 2021 || News analysis |

Written by CannIntelligence || 19th April 2021 || News analysis |

Written by CannIntelligence || 19th April 2021 || News analysis |

Written by CannIntelligence || 16th April 2021 || News analysis |

Written by CannIntelligence || 16th April 2021 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 15th April 2021 || News analysis |

Written by CannIntelligence || 14th April 2021 || News analysis |

Written by CannIntelligence || 14th April 2021 || Blogs |

Written by CannIntelligence || 14th April 2021 || News analysis |

Written by CannIntelligence || 13th April 2021 || News analysis |

Written by CannIntelligence || 13th April 2021 || News analysis |

Written by CannIntelligence || 12th April 2021 || News analysis |

Written by CannIntelligence || 9th April 2021 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 9th April 2021 || News analysis |

Written by CannIntelligence || 8th April 2021 || Blogs |

Written by CannIntelligence || 8th April 2021 || News analysis |

Written by CannIntelligence || 8th April 2021 || Regulatory reports |

Written by CannIntelligence || 7th April 2021 || News analysis |

Written by CannIntelligence || 6th April 2021 || News analysis |

Written by CannIntelligence || 6th April 2021 || News analysis |

Written by CannIntelligence || 1st April 2021 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 1st April 2021 || Blogs |

Written by CannIntelligence || 1st April 2021 || News analysis |

Written by CannIntelligence || 31st March 2021 || News analysis |

Written by CannIntelligence || 30th March 2021 || News analysis |

Written by CannIntelligence || 26th March 2021 || Presentations , Resources |

Written by CannIntelligence || 26th March 2021 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 26th March 2021 || News analysis |

Written by CannIntelligence || 25th March 2021 || News analysis |

Written by CannIntelligence || 25th March 2021 || Blogs |

Written by CannIntelligence || 24th March 2021 || Market data |

Written by CannIntelligence || 22nd March 2021 || Podcasts , Resources |

Written by CannIntelligence || 19th March 2021 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 19th March 2021 || News analysis |

Written by CannIntelligence || 19th March 2021 || News analysis |

Written by CannIntelligence || 18th March 2021 || Blogs , News analysis |

Written by CannIntelligence || 18th March 2021 || Market reports |

Written by CannIntelligence || 18th March 2021 || News analysis |

Written by CannIntelligence || 15th March 2021 || News analysis |

Written by CannIntelligence || 12th March 2021 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 12th March 2021 || News analysis |

Written by CannIntelligence || 11th March 2021 || Blogs |

Written by CannIntelligence || 11th March 2021 || News analysis |

Written by CannIntelligence || 10th March 2021 || News analysis |

Written by CannIntelligence || 9th March 2021 || Podcasts , Resources |

Written by CannIntelligence || 8th March 2021 || News analysis |

Written by CannIntelligence || 5th March 2021 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 5th March 2021 || News analysis |

Sign up to our newsletter

Start your FREE trial